221 related articles for article (PubMed ID: 1503678)
1. Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.
Uetrecht JP
Drug Saf; 1992; 7 Suppl 1():51-6. PubMed ID: 1503678
[TBL] [Abstract][Full Text] [Related]
2. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
Iverson S; Zahid N; Uetrecht JP
Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
[TBL] [Abstract][Full Text] [Related]
3. Reactive metabolites and agranulocytosis.
Uetrecht JP
Eur J Haematol Suppl; 1996; 60():83-8. PubMed ID: 8987247
[TBL] [Abstract][Full Text] [Related]
4. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.
Ng W; Kennar R; Uetrecht J
Chem Res Toxicol; 2014 Jul; 27(7):1104-8. PubMed ID: 24968069
[TBL] [Abstract][Full Text] [Related]
5. Structural features associated with reactive metabolite formation in clozapine analogues.
Uetrecht J; Zahid N; Tehim A; Fu JM; Rakhit S
Chem Biol Interact; 1997 May; 104(2-3):117-29. PubMed ID: 9212779
[TBL] [Abstract][Full Text] [Related]
6. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
7. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.
Maggs JL; Williams D; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1463-75. PubMed ID: 8531117
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes.
Gardner I; Zahid N; MacCrimmon D; Uetrecht JP
Mol Pharmacol; 1998 Jun; 53(6):991-8. PubMed ID: 9614200
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: implications for fluperlapine-induced agranulocytosis.
Lai WG; Gardner I; Zahid N; Uetrecht JP
Drug Metab Dispos; 2000 Mar; 28(3):255-63. PubMed ID: 10681368
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis.
Liu ZC; Uetrecht JP
Drug Metab Dispos; 2000 Jul; 28(7):726-30. PubMed ID: 10859143
[TBL] [Abstract][Full Text] [Related]
11. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells.
Liu ZC; Uetrecht JP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1476-83. PubMed ID: 8531118
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.
Pirmohamed M; Park K
CNS Drugs; 1997 Feb; 7(2):139-58. PubMed ID: 23338132
[TBL] [Abstract][Full Text] [Related]
13. Effect of clozapine on neutrophil kinetics in rabbits.
Iverson S; Kautiainen A; Ip J; Uetrecht JP
Chem Res Toxicol; 2010 Jul; 23(7):1184-91. PubMed ID: 20553052
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.
Williams DP; Pirmohamed M; Naisbitt DJ; Maggs JL; Park BK
J Pharmacol Exp Ther; 1997 Dec; 283(3):1375-82. PubMed ID: 9400013
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis.
Uetrecht JP; Zahid N; Whitfield D
J Pharmacol Exp Ther; 1994 Sep; 270(3):865-72. PubMed ID: 7932198
[TBL] [Abstract][Full Text] [Related]
16. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
Li X; Cameron MD
Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of clozapine-induced agranulocytosis.
Gerson SL; Meltzer H
Drug Saf; 1992; 7 Suppl 1():17-25. PubMed ID: 1503673
[TBL] [Abstract][Full Text] [Related]
18. Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis.
Lobach AR; Uetrecht J
Chem Res Toxicol; 2014 Apr; 27(4):699-709. PubMed ID: 24588327
[TBL] [Abstract][Full Text] [Related]
19. Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats.
Ip J; Wilson JX; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):869-73. PubMed ID: 18380445
[TBL] [Abstract][Full Text] [Related]
20. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions.
Uetrecht JP
Drug Metab Rev; 1992; 24(3):299-366. PubMed ID: 1628536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]